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Abstract
Adherent invasive Escherichia coli (AIEC) have been implicated as a causative agent of Crohn’s disease (CD) due to their
isolation from the intestines of CD sufferers and their ability to persist in macrophages inducing granulomas. The rapid
intracellular multiplication of AIEC sets it apart from other enteric pathogens such as Salmonella Typhimurium which after
limited replication induce programmed cell death (PCD). Understanding the response of infected cells to the increased AIEC
bacterial load and associated metabolic stress may offer insights into AIEC pathogenesis and its association with CD. Here
we show that AIEC persistence within macrophages and dendritic cells is facilitated by increased proteasomal degradation
of caspase-3. In addition S-nitrosylation of pro- and active forms of caspase-3, which can inhibit the enzymes activity, is
increased in AIEC infected macrophages. This S-nitrosylated caspase-3 was seen to accumulate upon inhibition of the
proteasome indicating an additional role for S-nitrosylation in inducing caspase-3 degradation in a manner independent of
ubiquitination. In addition to the autophagic genetic defects that are linked to CD, this delay in apoptosis mediated in AIEC
infected cells through increased degradation of caspase-3, may be an essential factor in its prolonged persistence in CD
patients.
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Introduction
Adherent invasive Escherichia coli (AIEC) is a Crohn’s Disease
(CD) associated pathogen that numerous studies have implicated
as a causative agent or contributory factor in disease pathology
[1,2,3,4]. AIEC are six times more likely to be isolated from ileal
samples of CD patients compared to controls and in intestinal
lesions from CD patients E. coli strains represented from 50 to
100% of the total bacteria present [1,5]. Further to this, AIEC
isolated from lesions of CD patients are capable of invading
epithelial cells and resisting phagocytosis [6]. While the idea of a
single bacterial causative agent in CD remains controversial, the
majority of host genetic mutations implicated in the disease are
linked to autophagy, a programmed cell death (PCD) pathway
intrinsically linked to the removal of intracellular bacterial
pathogens [7,8,9]. In total over 70 host genes, and counting,
have been linked to CD susceptibility, pointing to the importance
of innate immunity and autophagy as key factors in CD
development. Therefore a diminished ability of infected cells to
sense an intracellular microbe is no doubt a key feature in CD but
the mechanism of AIEC mediated persistence remains unchar-
acterized.
Unlike closely related species such as Shigella and Salmonella, and
even other pathogenic E. coli, AIEC and its virulence factors
remain poorly understood. Genome sequencing of LF82, the
AIEC type strain isolated from a lesion from a CD patient,
indicated that AIEC was most closely related to E. coli strains that
cause extra-intestinal infections such as meningitis and urinary
tract infections and also avian disease causing strains [10]. Despite
this, only 4 of 63 of these related E. coli strains shared the distinct
adherent invasive phenotype [10,11,12]. The uniqueness of AIEC
was further reinforced by the finding that 115 coding sequences
(CDS), or 2.6% of the genome are not found in any other E. coli
strain and 15 unique CDS not present in pathogenic prokaryotes
were also noted [10].
Once AIEC crosses the intestinal epithelium it comes into
contact with macrophages, a cell type in which it has been shown
to replicate extensively within the acidified phago-lysosome
[13,14]. AIEC in this environment has been reported to multiply
an unprecedented 70-fold within the first 48 hours of infection
[13]. This potent ability of AIEC to replicate extensively in
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macrophages while delaying PCD may be a critical factor in the
induction of unrestrained, chronic inflammation. While S.
Typhimurium inhibits apoptotic pathways through up-regulation
of host Akt activity through its phosphorylation by the secreted
effector SopB, this only allows only temporary inhibition of PCD
and any significant increases in bacterial cell number rapidly
induced apoptosis [15,16]. AIEC has no known effector with a
corresponding activity to that of SopB and the means by which
PCD is delayed in AIEC infected cells remains a mystery.
Programmed cell death as a response to bacterial infection has
been well defined with the roles of various PCD pathways in the
clearance of infection described in detail [17]. Numerous
pathogens however are known to successfully circumvent these
pathways, enabling them to establish persistent and sometimes
debilitating infections in the host. In the case of circulating
immune cells such as macrophages and dendritic cells (DCs) any
increase in lifespan of these cells can have detrimental effects on
host health with persistent immune cells leading to increases in
inflammation and tissue damage and the potential for develop-
ment of autoimmune diseases [18,19,20]. DCs play an important
role in CD with specific subsets contributing through the release of
high concentrations of pro- and anti-inflammatory cytokines
during disease [21]. Induction of the adaptive response by DCs
containing AIEC has the potential to exacerbate infection and by
disturbing the delicate immune homeostasis in the intestine reduce
tolerance to commensal bacteria. AIEC have already been shown
to replicate rapidly in intestinal macrophages without inducing
apoptosis and the possibility that this is also occurring in DCs
cannot be discounted [13].
Ubiquitination is known to be important in the host turnover
of apoptotic enzymes such as caspase-3 and caspase-7 with their
tagging by ubiquitin trafficking the enzymes for subsequent
proteasomal degradation [22,23]. Bacterial pathogens have been
implicated in the targeting of proteasomal recycling pathways
with the ubiquitination pathway in particular undermined
through the production of bacterial mimics of host E3 ubiquitin
ligases [24,25]. Turnover of caspases within host cells maintains
the basal enzyme levels below a certain threshold as a means of
reducing or controlling their activity and preventing inadvertent
apoptosis. Modifications such as S-nitrosylation can exert similar
anti-apoptotic effects by targeting the executioner caspase,
caspase-3, blocking its active site through the insertion of an
S-nitrosyl group, or priming it for subsequent ubiquitination and
proteasomal degradation [26,27]. The ability of bacterial
pathogens to utilize S-nitrosylation in the regulation of their
own proteins, or mimics of host enzymes such as ubiquitin
ligases, makes these host pathways potential targets of bacterial
virulence strategies [28].
Here we describe how during AIEC infection of macrophages
and DCs high levels of caspase-3 are trafficked to the proteasome
for degradation. At early time points proteasomal degradation of
caspase-3 was also seen in uninfected and commensal treated cells
indicating this may be a host mechanism of apoptosis control
exploited by AIEC. In addition, in macrophages infected with
AIEC high levels of S-nitrosylated pro- and active-caspase-3 were
observed and these modified forms accumulated after proteasome
inhibition in a ubiquitination independent manner. This is the first
description of the role of caspase-3 degradation in intracellular
survival of a bacterial pathogen and also the first account of
proteasomal degradation of S-nitrosylated active caspase-3. In
addition to the autophagic defects associated with CD this
inhibition of apoptosis by AIEC may be crucial to its persistence.
Materials and Methods
Bacterial Strains and Growth Conditions
Strains for infection were back-diluted after overnight growth
into 10 ml cultures of RPMI-1640 (Sigma) supplemented with 3%
Fetal Calf Serum (FCS) and L-glutamate. These were then grown
at 37uC in a shaking incubator at 200 rpm to an optical density of
0.6 before further dilution to give a final multiplicity of infection
(MOI) of 100. Strains used for infection were Salmonella enterica
serovar Typhimurium SL1344 [29], AIEC strain LF82 [1] and E.
coli F18, a commensal strain isolated from a human intestine [30].
Cell Culture and Maintenance
RAW 264.7 macrophages obtained from the European
Collection of Cell Cultures (ECACC) were maintained in
RPMI-1640 media (Sigma) supplemented with 10% FCS (Gibco),
L-glutamate and penicillin/streptomycin (both Sigma). The T84
human intestinal epithelial cell line obtained from the American
Type Culture Collection (ATCC) was maintained in a 50:50
mixture of Dulbecco’s Modified Eagles Medium and Hams F-12
Medium (both Sigma) supplemented with 10% FCS, L-glutamate,
15 mM HEPES buffer (pH 7.5), 14 mM sodium bicarbonate and
penicillin/streptomycin (Sigma-Aldrich). Cells were maintained at
37uC and 5% CO2 with regular media changes. RAW 264.7
macrophages were passaged before reaching 90% confluency
while T84 intestinal epithelial cells were passaged at 70%
confluency.
Isolation and Culture of Bone Marrow Derived Dendritic
Cells (BMDCs)
Bone marrow derived dendritic cells (BMDCs) were generated
using the Flt3 ligand as previously described [31,32]. Approval for
these procedures was given prior to their initiation by the
University of Glasgow ethics committee and by the U.K. Home
Office under License No. 60/4128. BMDCs were grown in
RPMI-1640 supplemented with 10% FCS, 10% Flt3 ligand, L-
glutamate and 50 mM ß-mercaptoethanol. After 7 days cells were
harvested, stained with fluorochrome conjugated monoclonal
antibodies to mouse antigens CD11c (3.9) and B220 (RA3-6B2)
(Biolegend) and samples were acquired on an LSR II (BD
Biosciences). Classical DCs (cDCs) compromised approximately
30% of total DC cultures and plasmacytoid DCs (pDCs)
approximately 31% (Fig. S1).
Infection of Cells
RAW 264.7 macrophages were seeded at 16105 cells per well of
a 24-well plate 48 hours prior to infection while BMDCs were
seeded at 16106 cells per well of a 24-well plate 24 hours prior to
infection. After 24 hours macrophages were treated with 100 ng/
ml lipopolysaccharide to induce an activated state. Infections for
both cell types were carried out in RPMI media supplemented
with 3% FCS and L-glutamate. Infections were carried out at an
MOI of 100. After 1 hour the bacteria that had not been
internalized were killed by adding 50 ng/ml gentamycin sulfate
(Sigma-Aldrich) and the infection allowed proceed. T84 epithelial
cells were seeded at 16105 cells per well 7 days prior to infection.
DMEM/Hams F-12 Media was changed at days 1 and 4 and a
100% confluent polarized monolayer of cells allowed form.
Infection was carried out at an MOI of 100 and after 2 hours
bacteria that had not invaded were killed by the addition of
gentamycin sulfate (50 ng/ml). Where stated MG132 (Sigma) an
inhibitor of the eukaryotic proteasome was added at a concentra-
tion of 10 mM while PYR-41 (Sigma) an inhibitor of eukaryotic E1
ubiquitin enzymes was used at a concentration of 50 mM. The
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inducible nitric oxide synthase (iNOS) inhibitor N-Nitro-L-
arginine methyl ester (L-NAME) (Sigma) was added to RAW
267.4 cells at a concentration of 100 mM where indicated. For
long-term infection experiments media was changed every 48
hours.
Enzyme Activity Assays Post-infection
Cell lysates were prepared post-infection by removing superna-
tants and scraping off cells in lysis buffer consisting of 2% Triton
X-100 in phosphate buffered saline (PBS) at pH 7.5. In addition
T84 cell lysates were passed 3 times through a 22-gauge syringe as
previously described [30]. Protease inhibitor (Complete Mini,
Roche) was added to PBS except where caspase-3 activity was
monitored as this inhibited caspase-3 protease activity. Both
supernatants and lysates were stored at 220uC until needed.
Lactate dehydrogenase (LDH) activity as a measure of cytoxicity
was measured in cell supernatants according the manufacturer’s
protocol (LDH Cytotoxicity Assay Kit, Abcam). For percentage
cytoxicity measurements PBS with 2% Triton-X-100 was as used a
positive control to lyse cells (100% cytotoxicity) while the
supernatant from uninfected cells was used as a low control (0%
cytotoxicity). LDH activity was expressed as a percentage of
control wells. In addition a Live/Dead Viability/Cytotoxicity kit
(Invitrogen) was used to examine levels of total cell death. The kit
was used according to the manufacturer’s protocol. Caspase-3
activity in cell lysates was measured using the Apo-One
Homogenous Caspase-3 Activity Kit (Promega). Post-measure-
ment caspase-3 activity was corrected for protein concentration
(BCA Protein Assay Kit, Pierce) and expressed as caspase-3
activity Fluorescence Focus Units (FFU) per mg of protein. All
enzyme activities were measured using a FluoStar Optima
fluorescent plate reader (BMG Biotech).
Concentration of Ubiquitin Tagged Proteins and Western
Blotting
Ubiquitin tagged proteins were concentrated post-infection by
passing lysates prepared in PBS, supplemented with 2% Triton-X-
100 and protease inhibitor (Complete-Mini, Roche), through a
ubiquitin pull-down column (Ubiquitin Enrichment Kit, Pierce) as
per the manufacturer’s instructions. During infection of cells to
enrich for proteins tagged with ubiquitin or ubiquitin like proteins
(UBLs) the proteasome inhibitor MG132 (Sigma) was added at a
concentration of 10 mM after invasion and gentamycin treatment
and maintained until harvesting of the cell lysates at the end of
infection as before. MG132 was used throughout this work for a
maximum of 6 hours to reduce any risk of cytotoxicity associated
with proteasomal inhibition. The lack of cytotoxicity over this time
was confirmed by LDH and Live/Dead Assays. For Western
blotting samples were separated through an 8–16% gradient Tris-
HCl Gel (Novex Gels, Invitrogen) by polyacrylamide electropho-
resis (SDS-PAGE) and transferred to nitrocellulose. Immunoblots
were performed using a 1:1000 dilution of antibodies against
caspase-3 and activated-caspase-3 (Cell Signalling Technology).
Goat anti-rabbit and goat anti-mouse IgG labeled with horserad-
ish peroxidase (Santa Cruz Biotechnology, Santa Cruz, CA)
diluted 1:2000 were used to detect bands and visualized by
enhanced chemiluminescence using the Super Signal ECL kit
(Pierce, Rockford, IL).
Bioinformatic Search for E3 Ubiquitin Ligase Mimics in
AIEC
All the CDSs in the genome of E. coli LF82 (NC_011993) and its
plasmid (CU638872) were collected using Artemis. The CDSs
were then uploaded to EffectorFAM, which is a database of
Hidden Markov Models for identifying effector proteins designed
within the Beatson group (University of Queensland). Since some
effectors such as SspH2 from Salmonella and YopM from Yesinia act
as ubiquitin ligase mimics EffectorFAM includes models for
predicting these proteins.
In addition the genome of LF82 was searched for the ubiquitin
ligase motif (CEDR) that has been identified in all bacterial
ubiquitin ligase mimics [33]. Pfam models that are based on the
conserved ubiquitin ligase domains were downloaded and used to
search the complete set of LF82 protein sequences. The Pfam
models that were used; Pfam ID – Description, PF09046 -
AvrPtoB E3 ubiquitin ligase; PF11547 - E3 ubiquitin ligase EDD;
PF13764 - E3 ubiquitin protein ligase UBR4; PF12483 - GIDE
(E3 ubiquitin ligase); PF08647 - BRE1 (E3 ubiquitin ligase);
PF00240 - ubiquitin. Next a character search for the ubiquitin
ligase motif (CEDR) was performed using Artemis (Genome
Research) but no significant matches could be found [34].
A final approach was to use the search tool tblastn (NCBI) to
compare the E3 ubiquitin ligase sequences against the nucleotide
sequence of the LF82 genome and plasmid [35]. The tool tblastn
compares a protein sequence to a nucleotide sequence by
translating the nucleotide sequences in all six frames. This method
allowed for the possibility that some CDSs were not predicted
when the genome was submitted.
Immunoprecipitation of S-nitrosylated Protein
Nitrosylated protein was labeled through an S–Nitrosylated
Protein Detection Assay Kit (Cayman Chemical Company). The
manufacturer’s protocol was modified to allow the immunopre-
cipitation of nitrosylated protein using streptavidin beads as
previously described [36]. Briefly, proteins were precipitated after
labeling through the use of 100% acetone and resuspended in
0.5 ml of 25 mM Hepes, 1 mM EDTA, 1% sodium dodecyl
sulphate (SDS). For streptavidin pull-down, 50 mg of protein from
each sample was diluted with 750 ml of neutralization buffer
(25 mM Hepes, 100 mM NaCl, 1 mM EDTA, 0.5% Triton X-
100, pH 7.7). This solution was tumbled overnight at 4uC with
30 ml of streptavidin agarose beads (Vector Laboratories), which
had been pre-washed with neutralization buffer. The beads were
pelleted at 2006g for 30 seconds, washed twice with neutralization
buffer containing 600 mM NaCl, pelleted and resuspended in
SDS–PAGE sample loading buffer. Supernatants of boiled
samples were separated by SDS–PAGE and immunoblotted for
pro- and active forms of caspase-3 as before.
Cytokine Assays
BMDCs and RAW 264.7 macrophages were maintained and
infected as described. At various time points post-infection
supernatants were collected and assayed for the p40 subunit (IL-
12, IL-23) or IL-10 production by cytokine ELISA kits
(BioLegend), according to the manufacturer’s instructions.
Detection of Nitric Oxide Levels
Nitric oxide levels were detected using the Griess Assay as
previously described but without use of the nitric oxide radical
scavenger PTIO after infection [37]. The reaction was read using
a FluoStar Optima microplate reader (BMG Biotech).
Statistical Analysis
All experimental results are expressed as the mean 6 standard
deviation of an individual experiment done in triplicate. P values
S-Nitrosylation Mediates AIEC Persistence
PLOS ONE | www.plosone.org 3 July 2013 | Volume 8 | Issue 7 | e68386
were calculated according to Student’s t test, and values ,0.05
were considered statistically significant.
Ethics Statement
All animal work was performed in strict accordance with the
requirements and guidelines of the Animals (Scientific Procedures)
Act 1986 outlining the humane and ethical treatment of laboratory
animals. Approval for these procedures was given prior to their
initiation by the University of Glasgow ethics committee and by
the U.K. Home Office (License No. 60/4128).
Results
AIEC have been reported to rapidly multiply in macrophage-
like cells suggesting that AIEC may actively inhibit activation of
PCD [13]. To test this further, we examined the role of PCD in
AIEC intracellular survival and replication in RAW 264.7
macrophages and murine bone marrow derived dendritic cells
(BMDCs). We hypothesized that during AIEC infection PCD is
actively inhibited allowing extended periods of AIEC intracellular
growth.
To understand in greater detail the host response to infection,
both RAW 264.7 cells and BMDCs were initially infected for 6
hours. This time point allowed us to study infection whilst also
avoiding any potential longer term cytotoxic side effects associated
with inhibiting either ubiquitination or proteasome activity. At 6
hours post infection (hpi) Live/Dead staining of the infected RAW
264.7 cells indicated no significant difference between samples
infected with S. Typhimurium, E. coli F18 or E. coli LF82 in
progression towards PCD (Fig. 1A). E. coli F18 is a commensal
non-pathogenic strain isolated from a human intestine while LF82
is the type strain for AIEC that was isolated from a CD patient
[30,38]. Similarly, caspase-3 activity used as an indicator of the
progression of RAW 264.7 cells toward apoptosis indicated no
difference at 6 hpi between uninfected and infected cell types
(Fig. 1B). To determine if degradation of caspase-3 via the
proteasome was masking increased levels of caspase-3 activity we
used MG132 (10 mM) to inhibit proteasomal activity allowing the
accumulation of proteins trafficked to the proteasome. Upon
addition of MG132 a 16.3-fold increase in caspase-3 activity was
observed in RAW 264.7 cells treated with the AIEC type strain
LF82 and to a lesser extent commensal E. coli F18 (14.3-fold) and
uninfected cells (6.0-fold). This indicates that caspase-3 is degraded
through the proteasome at high levels in AIEC and F18 infected
RAW 264.7 cells, but not in those infected with SL1344 (1.8-fold).
In order to study this phenomenon at a later time point in
infection, MG132 was added between 24 and 30 hpi. After
inhibition of the proteasome a 32-fold increase in caspase-3
activity was seen in LF82 infected cells (Fig. 1C). In F18 treated
cells caspase-3 activity was lower (12-fold) but in uninfected cells
the levels of activity increased approximately 90-fold. Again there
was little increase in accumulated caspase-3 activity in the SL1344
infected cells (2.4-fold) although at this point the bacterial numbers
recovered from RAW 264.7 cells were comparable for SL1344
{8.0 (66.0)6106} and LF82 {5.56 (63.71)6106} while no F18
were recovered. The further increase in caspase-3 degradation
between 24–30 hpi noted in LF82 infected RAW 264.7 cells was
unexpected given the level of intracellular bacteria present and it
was in stark contrast to virtually non-existent turnover of caspase-3
in SL1344 infected macrophages.
Pathogenic bacteria are known to infect and replicate within
circulating DCs which can then act as a means of spread from the
initial focal point of infection [39,40,41]. Using BMDCs (Fig. S1)
we firstly characterized the ability of LF82 and SL1344 to survive
and multiply within these cells with each showing a comparable
survival rate intracellularly over 48 hours while non-pathogenic E.
coli F18 was not recovered after 6 hpi (Fig. 2A). The level of
replication of LF82 within BMDCs was again comparable to
SL1344 but was not to the levels seen previously in macrophage-
like cells [13]. At 3, 6 and 10 hpi caspase-3 activity was not
significantly different between infected and uninfected BMDCs
(Fig. 2B) and there was no significant difference in the levels of
BMDC cytotoxicity induced by the bacteria at 3 hpi or at 6 hpi in
the presence or absence of MG132 (Fig. S2). However, as with
RAW 264.7 cells, upon blocking of proteasomal turnover with
MG132 (10 mM) there was again a dramatic accumulation of
caspase-3 activity in LF82 infected cells (8.7-fold) at 6 hpi (Fig. 2C).
This was in contrast to BMDCs treated with F18 (2.6-fold) and
also the control uninfected BMDCs (1.7-fold). Levels of caspase-3
activity in SL1344 infected cells (2.3-fold) mirrored those seen with
the commensal F18 strain. This indicates high levels of caspase-3
are targeted to the proteasome for degradation in LF82 infected
BMDCs. Again this is in contrast to BMDCs infected with
pathogenic SL1344 where caspase-3 turnover is low. Surprisingly,
and unlike in RAW 264.7 cells, in BMDCs caspase-3 turnover is
not seen to the same extent in uninfected cells and suggests that
different mechanisms of regulating apoptosis may be used in DCs.
In intestinal epithelial cells we had previously noted the crucial
role that caspase-3 plays during initial infection by SL1344 [29].
LF82 are also noted to adhere to and invade these cells causing
damage to intestinal epithelial cells and disrupting barrier integrity
[42]. To examine the role that caspase-3 turnover may play during
infection of the intestinal epithelium we utilized the T84 human
intestinal epithelial cell line and again treated with 10 mMMG132
to inhibit proteasome activity (Fig. 3). However, unlike circulating
immune cells we detected no increase in caspase-3 activity post-
MG132 addition indicating that proteasomal turnover of caspase-
3 is not a significant factor in intestinal epithelial cells at early time
points during infection or indeed in uninfected cells.
Caspase-3 degradation by the proteasome has been described as
a potential means of maintaining caspase-3 levels below the
threshold needed for the induction of apoptosis in the cell [23].
This form of protection from apoptosis has been described in
uninfected cells and can be mediated by ubiquitination or poly-
ubiquitination of caspase-3. Due to the presence of ubiquitin ligase
mimics in numerous bacterial strains we speculated that a
ubiquitin ligase mimic may also be present in LF82 that can
carry out this modification [24,43]. All the CDSs in the genome of
E. coli LF82 (NC_011993) and its plasmid (CU638872) were
collected using Artemis [34]. The CDSs were then uploaded to
EffectorFAM, a database of Hidden Markov Models for identi-
fying effector proteins designed within the Beatson group at the
University of Queensland. The genome of LF82 was searched for
the known ubiquitin ligase motif (CEDR) and also using Pfam
models based on known conserved ubiquitin ligase domains [33].
However, no hits corresponding to ubiquitin ligase mimics in LF82
were found with these models. A final approach confirmed these
findings using tblastn to compare the E3 ubiquitin ligase sequences
against the nucleotide sequence of the LF82 genome and plasmid
[35]. We concluded that it is highly unlikely that the E. coli LF82
genome encodes any ubiquitin ligase mimics.
The probable lack of a bacterial ubiquitin ligase mimic however
does not discount host mediated ubiquitination of caspase-3 as a
possible response to infection by LF82. To investigate this further,
ubiquitinated proteins were immunoprecipitated and probed for
caspase-3 but no ubiquitinated caspase-3 was observed (data not
shown). As the immunoprecipitation assay kit used was designed to
identify poly-ubiquitinated proteins we also carried out the reverse
S-Nitrosylation Mediates AIEC Persistence
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immunoprecipitation using anti-caspase-3 antibody and probed
for mono- or poly-ubiquitin but again no caspase-3 ubiquitination
was observed (data not shown). To conclusively discount the role
of ubiquitination in proteasomal degradation of caspase-3 during
LF82 infection, RAW 264.7 cells were treated with 50 mM PYR-
41. This inhibitor completely blocks the activity of the E1
activating enzyme that catalyzes the first step in ubiquitination.
Caspase-3 activity was not increased in the presence of PYR-41
and there was no alteration in caspase-3 accumulation upon
addition of MG132 indicating that ubiquitination is not respon-
sible for its targeting to the proteasome during LF82 infection
(Fig. 4A). Throughout this work there was no significant difference
in bacterial numbers within RAW 264.7 cells treated with PYR-41
or MG132, or a combination of both (Fig. 4B).
Alternative methods of caspase-3 modification were then
explored that could explain how it is targeted to the proteasome
for degradation. Caspase-3 can also be modified through a process
of S-nitrosylation, whereby an S-nitrosyl group is linked to the
active site cysteine of caspase-3 (Cys163) thus maintaining the
enzyme in an inactive state [26,27,44]. Using the biotin-switch
technique S-nitrosylated protein generated in the presence or
absence of MG132 was biotin labeled and immunoprecipitated
before being probed with anti-caspase-3 antibody [36,45] (Fig. 5).
S-nitrosylated caspase-3 was detected in all RAW 264.7 samples at
6 hpi. However with the addition of 10 mM MG132 to inhibit
proteasomal degradation there was a dramatic increase in S-
nitrosylated inactive pro-caspase-3 (p32) in the LF82, F18 and
uninfected samples. In addition, and most significantly, there was a
striking accumulation of S-nitrosylated active caspase-3 (p17) in
LF82 infected cells upon addition of MG132 while no S-
nitrosylated active caspase-3 (p17) was detected in SL1344 infected
or uninfected cells (Fig. 5 and S7). This indicates that in
Figure 1. Caspase-3 accumulates in LF82 infected RAW 264.7 cells after proteasome inhibition. (A) Cell death of RAW 264.7 cells at 6
hours post infection (hpi). The percentage of dead cells were calculated using a LIVE/DEAD stain and expressed as a percentage of the total number
of cells present per well of a 24 well plate. (B) Accumulation of caspase-3 activity in RAW 264.7 cells after proteasome inhibition from 0–6 hpi.
Caspase-3 activity in RAW 264.7 cells was measured at 6 hpi and expressed as activity, measured in fluorescence focus units (FFU) per mg of protein.
Measurements were carried out in the presence or absence of 10 mM MG132. (C) Accumulation of caspase-3 activity in RAW 264.7 cells after
proteasome inhibition from 24–30 hpi. Caspase-3 activity in RAW 264.7 cells was measured at 30 hpi and expressed as activity, measured in
fluorescence focus units (FFU), per mg of protein. Measurements were carried out in the presence or absence of 10 mM MG132. All experiments were
repeated at least three times in triplicate and data from representative experiments are shown. Data was analyzed by an unpaired Student’s t-test.
Statistically significant relationships are denoted. P values **,0.05, ***,0.005.
doi:10.1371/journal.pone.0068386.g001
Figure 2. Caspase-3 accumulates post-proteasome inhibition in LF82 BMDCs. (A) Recovery of bacteria post intracellular survival and
growth in BMDCs. After infection of BMDCs at an MOI of 100, bacteria were recovered and counted over 48 hpi. Intracellular growth curves were
repeated at least three times in triplicate and data from a representative experiment is shown. (B) Caspase-3 activity in BMDCs at 3, 6 and 10 hpi.
Caspase-3 activity was measured for the first 10 hpi and expressed as activity per mg of protein recovered. Caspase-3 activity assays were repeated at
least three times in triplicate and data from a representative experiment is shown. No significant difference was noted between LF82 infected and any
of the other infected or uninfected control cells. (C) Accumulation of caspase-3 activity in BMDCs after proteasome inhibition from 0–6 hpi. Caspase-3
activity in BMDCs was measured at 6 hpi and expressed as activity, measured in fluorescence focus units (FFU) per mg of protein. Measurements were
carried out in the presence or absence of 10 mM MG132. All experiments were repeated at least three times in triplicate and data from a
representative experiment is shown. Data was analyzed by an unpaired Student’s t-test. Statistically significant relationships are denoted. NS =Not
significant. P values *,0.01, **,0.05.
doi:10.1371/journal.pone.0068386.g002
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macrophages infected with LF82 there is a significant increase in
S-nitrosylation of both pro- and active caspase-3 and these
accumulate to high levels when the proteasome is inhibited. S-
nitrosylation of the active form of caspase-3 has not previously
been described in the literature and therefore this unique
modification may be a very direct means for persistent bacterial
pathogens to delay apoptosis.
S-nitrosylation levels within eukaryotic cells have been shown to
be intrinsically linked to nitric oxide levels the production of which
is increased during bacterial infection [46]. Nitric oxide (NO)
levels in infected RAW 264.7 cells were studied for any increase
upon LF82 infection and to ensure that MG132 treatment over
the first 6 hours of infection was not responsible for inducing an
increase in NO production. No significant difference in induced
NO was seen in infected or control RAW 264.7 cells at 6 hpi with
or without 10 mM MG132 treatment (Fig. 6). In addition in order
to further ensure that increased NO production over the first six
hours of infection was not having an effect on caspase-3 S-
nitrosylation and subsequent degradation we inhibited inducible
nitric oxide synthase (iNOS) using the iNOS specific inhibitor L-
NAME. This inhibition did not reduce the proteasomal dependent
accumulation of caspase-3 activity (Fig. 7). This further clarified
that the observed effect was not due to increased nitrosative stress
in response to LF82 infection of RAW 264.7 macrophages.
We lastly attempted to understand the significance of S-
nitrosylation of caspase-3 to long-term infection and inflammation
associated with LF82. The numbers of LF82 recovered from RAW
264.7 cells over the first 72 hours of infection mirrored those seen
with pathogenic SL1344 but were in contrast to commensal F18
which disappeared rapidly post infection. Interestingly, and
perhaps more significantly however, we did see persistence of
LF82 in RAW 264.7 cells that were maintained for 30 days post
infection (Fig. 8). This was in contrast to SL1344 and E. coli F18
infected RAW 264.7 cells where bacteria were not recovered 1 day
post infection for F18 and 5 days post infection for SL1344. In
addition studies of cytokine levels secreted by RAW 264.7 cells and
BMDCs over the first 72 hours of infection indicated that LF82
does not induce an increased inflammatory reaction when
compared to commensal E. coli F18 and it does not repress the
production of the anti-inflammatory cytokine IL-10 (Fig. S3–S6).
Together this data indicates that AIEC does not induce an acute
inflammatory response in RAW 264.7 cells or BMDCs. Therefore
persistence within immune cells mediated by S-nitrosylation of
caspase-3 may have an important role, both in inducing longer
term persistent inflammation through intracellular survival and
also acting as a seeding mechanism for further infection.
Figure 3. The effect of proteasome inhibition on caspase-3
activity in T84 intestinal epithelial cells from 0–6 hpi. Caspase-3
activity in T84s was measured at 6 hpi and expressed as activity,
measured in fluorescence focus units (FFU) per mg of protein.
Measurements were carried out in the presence or absence of 10 mM
MG132. Experiments were repeated at least three times in triplicate and
data from a representative experiment is shown. Data was analyzed by
an unpaired Student’s t-test. NS =Not significant.
doi:10.1371/journal.pone.0068386.g003
Figure 4. Caspase-3 build up in RAW 264.7 cells post-proteasome inhibition is independent of ubiquitination. (A) The effect of
inhibition of E1 ubiquitin activating enzymes on caspase-3 accumulation. RAW 264.7 cells were infected with LF82 or left uninfected (control) and
treated for 6 hpi with 10 mM MG132, 50 mM PYR-41 or a combination thereof (PYR/MG). Caspase-3 activity was measured and expressed as activity
per mg of protein recovered. Infected but untreated RAW 264.7 cells were used as controls also. Measurements were carried out in the presence or
absence of 10 mM MG132. (B) The effect of inhibition of ubiquitination and proteasomal degradation on bacterial intracellular survival. RAW 264.7
cells were infected with LF82 and treated for 6 hpi with 10 mM MG132, 50 mM PYR-41 or a combination thereof (PYR/MG). Bacterial colony counts
were then carried out on bacteria recovered from each well and expressed as colony forming units (cfu). Untreated and infected RAW 264.7 cells were
used as an additional control. Experiments were repeated at least three times in triplicate and data from a representative experiment is shown. Data
was analyzed by an unpaired Student’s t-test. Statistically significant relationships are denoted. NS =Not significant. P value **,0.05, ***,0.005.
doi:10.1371/journal.pone.0068386.g004
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Discussion
AIEC is an atypical opportunistic intestinal pathogen that differs
from acute pathogens such as S. Typhimurium in its ability to
carry out prolonged periods of intracellular replication. This rapid
intracellular growth is unprecedented amongst bacterial pathogens
and suggests a unique phenomenon whereby infected host cells are
maintained in a persistent state unable to induce PCD. Here we
show for the first time a unique phenotype for AIEC infected
RAW 264.7 cells and BMDCs with increased proteasomal
degradation of caspase-3 inhibiting the ability of AIEC infected
cells to induce apoptosis. This degradation of caspase-3 was
concomitant with increased S-nitrosylation of caspase-3 and
independent of ubiquitination which has previously been de-
scribed as the mediator of such degradation in uninfected cells
[23]. In addition to the already established ability of AIEC to
prosper in cells where autophagic defects have been noted, this
additional observation of the inhibition of apoptosis in AIEC
infected immune cells may explain why AIEC in particular, as
opposed to other intestinal pathogens, prosper under the
conditions noted in CD patients [1,5].
Bacteria that enter into the mammalian intestine can be divided
into three main types; bacteria that grow intracellularly causing
acute infection (S. Typhimurium), bacteria that grow intracellu-
larly and persist (AIEC,Mycobacterium species), and non-pathogenic
bacteria that are taken up and killed and are unable to instigate
intracellular replication (commensals). The reasons behind AIEC
persistence intracellularly have to date remained elusive and
cannot be explained by the autophagic defects associated with CD
as these were not found in macrophages in which AIEC were
initially shown to replicate so effectively [13]. Surprisingly when
PCD was analyzed, the host response to AIEC differed dramat-
ically from that of another intestinal pathogen S. Typhimurium,
with the response to AIEC at early time points mirroring the
apoptosis and necrosis levels seen with a non-pathogenic
commensal strain of E. coli. As proteasomal degradation of
caspase-3 has previously been described as a means of preventing
caspase-3 build up and averting spontaneous apoptosis in
uninfected cells we speculated that similarly, despite rapid
intracellular growth, caspase-3 is maintained below threshold
levels in AIEC infected cells [22,23]. Increased turnover of
caspase-3 in the E. coli treated host cells for the first 6 hpi occurred
at a level similar to that seen in uninfected cells and in contrast to
S. Typhimurium infected cells where caspase-3 turnover was not
seen. Caspase-3 turnover in AIEC infected cells further increased
at 24 hpi but remained unchanged and at low levels in S.
Typhimurium infected cells. As S. Typhimurium also grows
intracellularly, albeit for a shorter period during acute infection,
we concluded that these pathogens employ vastly different
strategies to inhibit apoptosis. S. Typhimurium inhibition of
PCD is dependent on SopB phosphorylation and activation of the
apoptosis inhibitor Akt as previously described and not through
caspase-3 turnover as is the case with AIEC [47]. Therefore, it is
likely that caspase-3 levels are tightly controlled in S. Typhimur-
ium infected immune cells, removing the need to later induce its
degradation in a manner similar to AIEC. Proteasomal degrada-
Figure 5. Build-up of S-nitrosylated forms of caspase-3 in RAW 264.7 macrophages when the proteasome is inhibited. S-nitrosylated
proteins were probed with anti-caspase-3 antibody to examine accumulation of pro- (p32) and active (p17) forms of caspase-3 after inhibition of
proteasomal degradation with 10 mM MG132. Western blotting was repeated three times and a representative Western blot is shown.
doi:10.1371/journal.pone.0068386.g005
Figure 6. Nitric oxide production in RAW 264.7 cells 6 hpi. NO levels in the supernatants of RAW 264.7 cells were measured using the Griess
assay. Levels in cells treated with MG132 (10 mM) were lower than untreated cells but there was no significant difference between any of the
uninfected samples or controls. This decrease in NO production upon MG132 addition indicated that the increase in S-nitrosylation of caspase-3 was
not due to increased NO production in response to infection. Experiments were repeated at least three times in triplicate and data from a
representative experiment is shown.
doi:10.1371/journal.pone.0068386.g006
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tion of caspase-3 was also seen in RAW 264.7 cells and BMDCs
upon the uptake of commensal bacteria and in uninfected cells
implying this is also a strategy employed to prevent spontaneous
cell death in the absence of infection. While AIEC intracellular
levels increased over the first 6 hpi E. coli F18 was completely
removed. Yet no significant difference in the rate of proteasomal
degradation of caspase-3 between these treated cells was noted in
RAW 264.7 cells or BMDCs with these cells apparently unable to
distinguish the pathogenic potential of AIEC.
Ubiquitination of caspase-3 is a mechanism utilized by
uninfected cells to maintain a basal level of caspase activity within
cells thus preventing apoptosis and extending their lifespan
[22,23]. We speculated that mimics of host ubiquitin ligases, the
enzymes that carry out this reaction, may be present in AIEC as
they have been found in intestinal pathogens including a number
of pathogenic E. coli strains [24,25]. However despite in depth
screening no ubiquitin ligase mimics were detected in LF82, the
type strain of AIEC. In addition complete inhibition of
ubiquitination in AIEC infected cells using the chemical inhibitor
of E1 activating enzymes had no effect on proteasomal degrada-
tion of caspase-3. This is not unprecedented as numerous viral
infections induce proteasomal degradation of host proteins in a
ubiquitin independent manner although the mechanism or
pathway involved has to date remained elusive [40,48].
Alternative modifications of caspase-3 have been described in
the literature with S-nitrosylation of caspase-3 the most interesting
given its role in caspase-3 turnover and also its ability to inhibit
caspase-3 activity [44,49]. In addition the recent description of
roles for host derived nitrates in facilitating E. coli infection of the
gut and for nitric oxide during M. tuberculosis infection add to the
significance of these nitrosyl modifications during persistent
infection [50]. During S-nitrosylation an S-nitrosyl group is
Figure 7. The effect of iNOS inhibition on the observed increase in caspase-3 activity post-proteasomal blocking. RAW 264.7 cells
were infected with LF82 and treated with or without the proteasomal inhibitor MG132 (10 mM) as before. Addition of the iNOS inhibitor L-NAME
(100 mM) did not cause any decrease in caspase-3 activity in cells where the proteasome was blocked. P-value NS (Not significant).
doi:10.1371/journal.pone.0068386.g007
Figure 8. Recovery of bacteria from RAW 264.7 cells up to 30 days post infection. RAW 264.7 cells were infected as described and
maintained in 3% FCS for a period of 30 days with regular media changes and maintenance of gentamycin at 50 mg/ml. Intracellular bacteria were
harvested as before by lysing RAW 264.7 cells. Experiments were repeated at least three times in triplicate and data from a representative experiment
is shown. Data was analyzed by an unpaired Student’s t-test. Statistically significant relationships are denoted. P value ***,0.005.
doi:10.1371/journal.pone.0068386.g008
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reversibly attached to the active site cysteine residue (C163) of
caspase-3 inhibiting enzymatic activity [26]. Upon addition of the
proteasomal inhibitor MG132 to AIEC infected cells, a significant
increase was noted in S-nitrosylated caspase-3 protein levels
indicating that S-nitrosylation was trafficking caspase-3 to the
proteasome. This occurs independently of ubiquitination but
whether S-nitrosylation alone is capable of inducing proteasomal
degradation is unknown. Previous studies have characterized S-
nitrosylation of proteins as acting as a primer for ubiquitination
and subsequent proteasomal degradation so it cannot be ruled out
that although ubiquitination is not responsible, an alternative
pathway may cause subsequent additional modifications to
caspase-3 post-nitrosylation [51].
AIEC infected RAW 264.7 cells exhibited a startling turnover of
activated, as well as pro-, caspase-3, a phenomenon to our
knowledge that has not been described in the literature (Fig. 5).
This accumulation of active caspase-3 after proteasome inhibition
suggests that AIEC infected cells are capable of converting pro-
caspase-3 into its activated form in response to AIEC infection in
order to undergo apoptosis. This activated caspase-3 however,
which was seen at approximately 10-fold higher levels in AIEC
infected cells when the proteasome was blocked, is trafficked for
degradation or rendered inactive by S-nitrosylation. Pro-caspase-3
is known to be inhibited by S-nitrosylation of the active site
cysteine, preventing any inadvertent activity. However, to our
knowledge this is the first description of S-nitrosylation of the
active form of caspase-3 and so it is not known if the S-nitrosyl
group can attach to the active site cysteine or if modification of the
enzyme occurs at an alternative cysteine residue. The effect of S-
nitrosylation of active caspase-3 on the enzymes activity is
unknown but our data has led us to speculate it has a similar
inhibitory effect. While our enzyme activity assays for caspase-3
indicate a high turnover of caspase-3 through proteasomal
degradation, in AIEC infected cells there is an additional
accumulation of active caspase-3 in the cell that may not be
detected due to S-nitrosylation of its active site rendering it
inactive. This would explain the far higher levels of active caspase-
3 detected by western blotting in AIEC infected RAW 264.7 cells
not being fully reflected in caspase-3 enzyme activity assays.
S-nitrosylation of caspase-3 can be host-mediated with numer-
ous studies implicating nitric oxide (NO), X-linked inhibitor of
apoptosis (X-IAP) and thioredoxin in the induction of caspase-3 S-
nitrosylation [44,46,52,53,54]. Seven different caspases are inhib-
ited by NO mediated reversible S-nitrosylation and NO, in
addition to thioredoxin, is known to cause S-nitrosylation of the
critical cysteine residue in the active site of caspase-3 [44,46]. The
mechanism of caspase-3 S-nitrosylation has yet to be elucidated
although the production of NO in response to infection by AIEC
could induce the inhibition of caspase-3 in an indirect manner.
Indeed during viral infection inducible nitric oxide synthase
(iNOS) activity was found to have an anti-apoptotic effect and NO
increases survival of monocytes by influencing caspase-3 and
caspase-9 activation [55,56]. However, during LF82 infection
there was no significant difference in NO production between
LF82 infected RAW 264.7 cells and other infected or control cells
suggesting a role for NO is unlikely (Fig. 6). In addition, inhibition
of iNOS through the use of the iNOS specific inhibitor L-NAME
had no effect on the accumulation of caspase-3 activity after the
addition of MG132 to inhibit the proteasome (Fig. 7). These
results suggest that an increase in intracellular NO levels is not
responsible for mediating caspase-3 S-nitrosylation and degrada-
tion during acute LF82 infection. As S. Typhimurium is known to
actively inhibit pathways linked to NO production it may be the
case that AIEC also inhibits NO production to promote
intracellular survival and this is currently being further examined
along with potential roles for host X-IAP and thioredoxins in this
process [57].
While S-nitrosylation of caspase-3 we believe is most likely host-
mediated the potential role of bacterial virulence factors cannot be
discounted. AIEC does not express a type III secretion system
(T3SS) but is known to encode a type VI secretion system (T6SS)
and is speculated to use outer membrane vesicles (OMVs) as a
means of bacterial protein delivery [10,58]. While classical
virulence factors have not been found in the AIEC genome the
presence of numerous uncharacterized genes allows for the
possibility that unique virulence factors or toxins are being
delivered into host cells. The potential overlap in function between
S-nitrosylation pathways in bacteria and host cells may also be
significant with bacteria, including LF82, expressing proteins that
mediate S-nitrosylation of their own bacterial proteins [59,60].
LF82 in addition encodes two thioredoxins that share homology
with mammalian thioredoxins, proteins that are known to S-
nitrosylate caspase-3 [10,44].
While S-nitrosylation could be carried out directly by a bacterial
virulence factor an indirect effect through perturbation of host cell
pathways appears more plausible. The transfer of S-nitrosyl groups
between specific proteins, or transnitrosylation, plays a crucial role
in controlling the apoptotic cascade with S-nitrosylation converse-
ly controlling the activation state of both pro- and anti-apoptotic
proteins. With the X-linked inhibitor of apoptosis (XIAP) known
to transnitrosylate caspase-3, and vice versa, it is possible that
inhibition of this XIAP reaction may also be targeted by AIEC in a
similar fashion to Pseudomonas aeruginosa which stabilizes XIAP and
delays apoptosis during infection [61]. Perturbation of such a
transnitrosylation reaction would maintain caspase-3 in an inactive
state while XIAP, without an S-nitrosyl group, would remain
constitutively active meaning apoptosis would be inhibited in two
distinct ways.
The outcome of AIEC maintaining immune cells in a persistent
state has potential to contribute to and exacerbate intestinal
inflammation. Increases in the lifespan of immune cells can be
detrimental to intestinal homeostasis through the release of pro-
inflammatory cytokines and in some cases is speculated to
contribute to the development of autoimmune disorders
[18,19,20]. Upon examination of cytokine levels released by
infected RAW 264.7 cells or BMDCs over the first 72 hours of
infection E. coli treated cells secreted more pro-inflammatory p40
(IL-12/23) than SL1344 infected cells. However there was no
significant difference between levels of p40 (IL-12/23) or anti-
inflammatory IL-10 released by RAW 264.7 cells or BMDCs
treated with LF82 or non-pathogenic F18 (Fig. S3–S6). The role of
these cytokines in longer term infections is currently being further
examined. However we could recover AIEC up to 30 days post-
infection of RAW 264.7 cells at levels of approximately {5.67
(64.97)6104} per well (Fig. 8). In contrast no SL1344 or F18 were
recovered after 5 days or 1 day of infection respectively. Therefore
the possible presence of a sub-population of persistent cells within
the AIEC population cannot be over looked. Persister cells, an
increasingly resistant sub-population of bacteria that develop
during infection, have been described for other pathogens
especially those that form biofilms [62]. For AIEC persister cells
may play a crucial role in maintaining a percentage of the
macrophage and DC population infected and in a heightened
inflammatory state. These AIEC upon their release from infected
cells could act as a seeding mechanism for further infection,
contributing to the persistent nature of infection as is seen in CD.
In this regard rapid intracellular replication as previously reported
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may not be as important as the ability to persist within immune
cells [13].
AIEC in the future will need to be examined as a pathogen that
is not just an opportunist that can target cells defective in
autophagy but as a pathogen with a distinct mechanism of
infection and persistence independent of autophagy. This inhibi-
tion of apoptosis in immune cells infected with AIEC explains why
AIEC as opposed to numerous other intestinal pathogens can
persist so well in autophagy defective cells. An inability to remove
cells through autophagy coupled with an apoptotic defect induced
by AIEC infection would greatly restrict the ability of an infected
cell to respond to intracellular AIEC. Understanding this dual role
for PCD during AIEC infection would open up a new front in our
attempts to combat AIEC induced inflammation.
Supporting Information
Figure S1 Generation of bone marrow derived dendritic
cells (BMDCs) from C57/Bl6 mice. BMDCs were derived
using Flt3 ligand and after 7 days cells were harvested and
analyzed by flow cytometry (LSR II BD Biosciences). Classical
DCs (cDCs) compromised approximately 30% of cells, with 31%
plasmacytoid (pDCs).
(TIF)
Figure S2 Cytotoxicity in RAW 264.7 cells post-infection
as an indicator of necrosis. LDH activity was measured for
the first 10 hpi and expressed as activity per mg of protein
recovered. LDH activity assays were repeated at least three times
in triplicate and data from a representative experiment is shown.
Data was analyzed by an unpaired Student’s t-test and showed no
significant difference in cytotoxicity levels between any of the
infected or control samples at 3 and 6 hours, with or without
10 mM MG132.
(TIF)
Figure S3 IL-10 release by RAW 264.7 cells over the first
72 hpi. IL-10 release by RAW 264.7 cells was monitored over the
first 72 hpi by sampling supernatants of infected RAW 264.7 cells
and subjecting these to ELISA analysis. All cytokine experiments
were carried out in triplicate and cytokine levels were measured in
at least three independent experiments. Data was analyzed by an
unpaired Student’s t-test. Statistically significant relationships are
denoted. NS=Not significant. P values ***,0.005.
(TIF)
Figure S4 IL-12/23 p40 release by RAW 264.7 cells over
the first 72 hpi. The release of the p40 subunit common to both
IL-12 and IL-23 was monitored over the first 72 hpi by sampling
supernatants of infected RAW 264.7 cells and testing these by
ELISA. Data was analyzed by an unpaired Student’s t-test.
Statistically significant relationships are denoted. NS=Not
significant. P values ***,0.005.
(TIF)
Figure S5 IL-10 release by BMDCs over the first 72 hpi.
The release of IL-10 was monitored over the first 72 hpi by
sampling supernatants of infected BMDC cultures and testing
these by ELISA. Data was analyzed by an unpaired Student’s t-
test. Statistically significant relationships are denoted. NS=Not
significant. P values *,0.01, **,0.05, ***,0.005.
(TIF)
Figure S6 IL-12/23 p40 release by BMDCs cells over the
first 72 hpi. The release of the p40 subunit common to both IL-
12 and IL-23 was monitored over the first 72 hpi by sampling
supernatants of infected BMDC cultures and testing these by
ELISA. Data was analyzed by an unpaired Student’s t-test.
Statistically significant relationships are denoted. NS=Not
significant. P values ***,0.005.
(TIF)
Figure S7 Densitometric analysis of S-nitrosylated
caspase-3 levels. S-nitrosylated caspase-3 levels in RAW
264.7 cells (Figure 5) was subjected to densitometric analysis.
Levels of S-nitrosylated pro-caspase-3 (A) ad active caspase-3 (B) in
samples were compared to those of control uninfected samples
which had not been treated with MG132 (10 mM). Analysis was
carried out on three separate blots and a representative analysis is
shown.
(TIF)
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